• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Drug Delivery - Analysis of Cutting-Edge Technologies and Trends Product Image

Drug Delivery - Analysis of Cutting-Edge Technologies and Trends

  • ID: 364005
  • December 2004
  • Frost & Sullivan



Patent expiration and the subsequent competitive pressure from generic manufacturers are compelling pharmaceutical companies to adopt innovative drug delivery techniques for enhancing the value of their blockbuster drugs. Improved drug delivery not only increases the safety, efficacy, and patient compliance but also enables the company to charge a premium for the enhancements in current products. They can then reduce the prices of the original drug to compete on a level footing with the lower priced generics. Numerous drug delivery companies are also developing their own drugs combined with innovative delivery platforms. This is expected to reduce dependency on major pharmaceutical companies for newer drugs and simultaneously augment market revenues.

This report analyzes developments in novel and emerging oral, parenteral, transdermal, and inhalation drug delivery technologies. In addition to evaluating research trends in key companies and universities across the globe, this study evaluates the important technology drivers and challenges. Participants can use this research service to identify potential collaborators, stay ahead of the competition, and remain abreast READ MORE >

Note: Product cover images may vary from those shown

1. Executive Summary

- 1. Introduction

- - 1. Introduction to Drug Delivery (Technologies)

- - 2. A Current Overview of Drug Delivery Industry

- 2. Scope & Methodology

- - 1. Scope & Segmentation of the Research Service

- - 2. Methodology

2. Oral Drug Delivery Technologies

- 1. Research in Private Sector

- - 1. Ultrafast Melting Oral Tablets to Tackle Dysphagia - United States

- - 2. Oral Drug Delivery Platform to Enhance Therapeutic Benefit - United States

- - 3. Casein Coating to Deliver Insulin Through the Oral Route - United States

- - 4. Customized Oral Drug Release Technology - Italy

- - 5. Starch Capsule for Delivering Medication to Colon - United States

- 2. Research in Public Sector

- - 1. Exploring Adhesive Proteins Secreted by Marine Mussel for Oral Delivery - United States

- - 2. Micropump and Sensors for Oral Drug-Delivery - Canada

3. Parenteral Drug Delivery Technologies

- 1. Research in Private Sector

- - 1. Controlled Release Microparticle Technology for Parenteral Delivery of Drugs - United States

- - 2. Explore Nanomagnetic Particles for Cancer Therapy - United States

- - 3. Thermogelling Polymer Solution for Parenteral Delivery - Canada

- - 4. Pump Delivers Protein Drugs at Low Flow Rates - United States

- - 5. Drug-Eluting Bead Embolization; a Potentially Precise Treatment of Liver Cancer - UK

- - 6. Biosilicon to Provide Cleaner and Defined Drug Delivery -- Australia

- 2. Research in Public Sector

- - 1. Precise Drug Delivery through Echogenic Liposomes - United States

- - 2. Polymer Platform for Delivering Drugs to Tumor Sites - UK

- - 3. Polymer Beads to Deliver Drugs for Inflammatory Disease - United States

- - 4. Polymer Microspheres to Enable Controlled and Precise Drug Delivery - United States

- - 5. Virus to Improve Selectivity and Efficiency of Gene Delivery - UK

4. Transdermal Drug Delivery Technologies

- 1. Research in Private Sector

- - 1. Nontoxic and Versatile Skin Permeation Enhancers - United States

- - 2. Pain-Free Injection Device for Delivering Anesthesia - United States

- - 3. Silicone Microneedles for Better Transdermal Drug Delivery - Israel

- - 4. Transdermal Gel to Deliver Hormone Therapy - United States

- - 5. A New Trend in Dermatological Drug Delivery; Foamy Carriers - Israel

- 2. Research in Public Sector

- - 1. Deliver Insulin with Ultrasound Device - United States

- - 2. Microscission to Deliver Drugs Painlessly Through the Skin - United States

- - 3. Microchip to Deliver Drugs Transdermally - United States

- - 4. Skin Penetration Enhancers for Transdermal Delivery - United States

5. Nasal and Inhalation Drug Delivery Technologies

- 1. Research in Private Sector

- - 1. Dry Powder Inhalers for Consistent and Inexpensive Pulmonary Drug Delivery - United States

- - 2. Advanced Pulmonary and Combination Oral Solid Delivery Technologies - United States

- - 3. Novel Pulmonary Delivery Technology for Protein and Peptide Macromolecules - UK

- - 4. Formulation Technology to Increase Nasal Retention of Drugs - United States

- - 5. Device to Simplify Drug Delivery Through the Nasal Route - Denmark

- - 6. Intelligent Inhaler for Precise Pulmonary Delivery - UK

- 2. Research in Public Sector

- - 1. Coating to Prevent Systemic Absorption of Pulmonary Drugs - United States

- - 2. Polymer Spheres to Directly Deliver Drugs to Lungs - United States

6. Drug Delivery Technology Analysis

- 1. Drug Delivery Technologies - Drivers and Challenges

- - 1. Technology Adoption Drivers

- - 2. Technology Challenges

- 2. Technology Bottlenecks Trend Analysis and Regulatory Climate

- - 1. Technology Bottlenecks

- - 2. Future Development Trends in Technology

- - 3. Regulatory Impact on Industry

7. Patents; Contacts

- 1. Patents Related to Drug Delivery

- - 1. Patents Related to Oral Delivery

- - 2. Patents Related to Parenteral Delivery

- - 3. Patents Related to Transdermal Delivery

- - 4. Patents Related to Inhalation Delivery

- 2. Contacts

- - 1. Companies

- - 2. Universities

8. Frost & Sullivan 2005 Science and Technology Awards

- 1. Technology Leadership Award

- - 1. Award Description

- - 2. Award Recipient

- 2. Excellence in Technology Award

- - 1. Award Description

- - 2. Award Recipient

- 3. Technology Innovation Award

- - 1. Award Description

- - 2. Award Recipient

9. Critical Reference Tables

- 1. Healthcare Expenditure

- - 1. Government Healthcare Expenditure (1999 to 2006)

- - 2. Private Healthcare Expenditure (1999 to 2006)

- - 3. Total Healthcare Expenditure (1999 to 2006)

- - 4. Percentage Healthcare Expenditure (1999 to 2006)

- - 5. Per Capita Healthcare Expenditure (1999 to 2006)

- 2. Pharma R&D Expenditure

- - 1. Pharmaceuticals R&D Expenditure (1999 to 2006)

- - 2. Percentage Pharmaceuticals R&D Expenditure (1999 to 2006)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos